From the Study of DNases to Cancer Research: An Unexpected Scientific Journey
MetadataShow full item record
In 2018, the National Cancer Institute diagnosed 1.7 million new cases of cancer in the United States. The effect of this disease is felt throughout the country as millions of families are affected. To shed some light on this disease, Texas A&M International University's (TAMIU) Presidential Lecture Series brings to the forefront leading scientific expert Dr. Renato Aguilera with a lecture titled, "From the Study of DNases to Cancer Research: An Unexpected Scientific Journey," on Wednesday, Feb. 6 at 6:30 p.m.in the Center for the Fine and Performing Arts’ Recital Hall. The event is free and open to the public. The recipient of several research and training grants, Aguilera currently serves as a professor in the Department of Biological Sciences at The University of Texas at El Paso. He earned his Ph.D. in Immunology from the University of California at Berkley and a Master’s degree in Immunochemistry from UT- El Paso. As a graduate student, Aguilera began his laboratory studying a mammalian endonuclease he discovered. After working on the enzyme for several decades, Aguilera’s research group at the University of California-Los Angeles purified the DNase II enzyme, eventually cloning the human gene and obtaining a US patent for the unique enzyme. During the talk, Aguilera will discuss his previous work on DNase II, as well as his current pursuit of cancer research that focuses on screening the chemical libraries on human cancer cells to discover anti-cancer therapeutics. Organized through TAMIU’s University College, the Presidential Lecture Series is an occasional series at the University that seeks to bring innovative thinkers and creators to the University in public lectures open to both students and the University community at large.